Ā | AUC (95% CI) | Sensitivity (%) | Specificity (%) |
---|---|---|---|
Training cohort | Ā | Ā | Ā |
Clin-US Nomogram | 0.813 (0.790ā0.835) | 57.22 | 83.58 |
Sex | 0.538 (0.512ā0.563) | 78.65 | 28.88 |
Position | 0.567 (0.536ā0.598) | 72.24 | 40.37 |
Tumor size | 0.665 (0.632ā0.694) | 37.92 | 83.96 |
Multifocality | 0.613 (0.584ā0.641) | 68.48 | 54.01 |
Mircocacification | 0.575 (0.556ā0.593) | 24.08 | 90.91 |
Ā A/P>0.25 | 0.692 (0.669ā0.714) | 53.83 | 84.49 |
Internal testing cohort | Ā | Ā | Ā |
Clin-US Nomogram | 0.815 (0.775ā0.854) | 58.47 | 81.52 |
Sex | 0.574 (0.526ā0.621) | 78.26 | 36.44 |
Position | 0.522 (0.467ā0.577) | 68.70 | 35.59 |
Tumor size | 0.659 (0.613ā0.705) | 36.96 | 88.14 |
Multifocality | 0.636 (0.586ā0.685) | 66.96 | 60.17 |
Mircocacification | 0.584 (0.558ā0.610) | 21.09 | 95.76 |
Ā A/P>0.25 | 0.703 (0.663ā0.744) | 56.74 | 83.90 |
External testing cohort | Ā | Ā | Ā |
Clin-US Nomogram | 0.870 (0.822ā0.917) | 89.47 | 80.57 |
Sex | 0.586 (0.523ā0.648) | 78.26 | 38.89 |
Position | 0.583 (0.513ā0.654) | 47.83 | 69.44 |
Tumor size | 0.789 (0.730ā0.849) | 80.43 | 73.61 |
Multifocality | 0.564 (0.497ā0.630) | 61.30 | 51.39 |
Mircocacification | 0.628 (0.577ā0.680) | 39.57 | 86.11 |
Ā A/P>0.25 | 0.743 (0.682ā0.803) | 87.39 | 61.11 |